Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Modular Medical, Inc.MODD · Entity 7488 | Director | September 30, 2026 | October 02, 2026 |
| TACTILE SYSTEMS TECHNOLOGY INCTCMD · Entity 5451 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Modular Medical, Inc.
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,036 |
Reported balance
After 2026-09-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 108 · Balance 1,036 F1: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan. F2: Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.
F2: Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.
TACTILE SYSTEMS TECHNOLOGY INC
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,219 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 6,521 · Balance 44,219 F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ANTARES PHARMA, INC.
Report date May 24, 2022 · Filed May 26, 2022
Section 16 reporting ended · disclosed 2022-05-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.48 | Direct | 0 |
Reported balance
After 2022-05-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-24 · Disposition to issuer · Disposed 55,916 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 12, 2022, by and among the Issuer, Antares Pharma, Inc., a Delaware corporation (the "Company"), Halozyme Therapeutics, Inc., a Delaware corporation ("Parent"), and Atlas Merger Sub, Inc., a Delaware corporation ("Purchaser") and a wholly owned subsidiary of Parent, to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.01 par value per share (each, a "Share") and thereafter merged with and into the Issuer (the "Merger") effective as of May 24, 2022 (the "Effective Time"). F2: (Continued from Footnote 1) At the Effective Time, each Share outstanding immediately prior to the Effective Time (other than Excluded Shares) was converted into the right to receive $5.60 in cash, without interest (the "Merger Consideration") and subject to any withholding of taxes required by applicable legal requirements, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled. F3: Each Company option to purchase Shares ("Company Option") means any option to purchase Shares granted under the Company Equity Plan. At the Effective Time, each Company Option that was then outstanding as of immediately prior to the Effective Time was, to the extent unvested, accelerated and became fully vested and exercisable effective prior to the Effective Time. Each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of Shares subject to such Company Option immediately prior to the Effective Time, multiplied by (ii) the excess of (A) the Merger Consideration over (B) the exercise price payable per Share under such Company Option. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 12, 2022, by and among the Issuer, Antares Pharma, Inc., a Delaware corporation (the "Company"), Halozyme Therapeutics, Inc., a Delaware corporation ("Parent"), and Atlas Merger Sub, Inc., a Delaware corporation ("Purchaser") and a wholly owned subsidiary of Parent, to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.01 par value per share (each, a "Share") and thereafter merged with and into the Issuer (the "Merger") effective as of May 24, 2022 (the "Effective Time").
F2: (Continued from Footnote 1) At the Effective Time, each Share outstanding immediately prior to the Effective Time (other than Excluded Shares) was converted into the right to receive $5.60 in cash, without interest (the "Merger Consideration") and subject to any withholding of taxes required by applicable legal requirements, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled.
F3: Each Company option to purchase Shares ("Company Option") means any option to purchase Shares granted under the Company Equity Plan. At the Effective Time, each Company Option that was then outstanding as of immediately prior to the Effective Time was, to the extent unvested, accelerated and became fully vested and exercisable effective prior to the Effective Time. Each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of Shares subject to such Company Option immediately prior to the Effective Time, multiplied by (ii) the excess of (A) the Merger Consideration over (B) the exercise price payable per Share under such Company Option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 02:26 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 108 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-26-105960 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,036 F1 · price: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan. F2 · balance_after: Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:30 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 110 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-26-075011 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 916 F1 · price: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan. F2 · balance_after: Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026. Read SEC document |
| May 06, 2026 Filed May 8, 2026 21:29 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 6,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001282953-26-000002 · form4-05082026_090506.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,219 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| March 31, 2026 Filed Apr 8, 2026 21:00 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 103 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-26-041554 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 806 F1 · price: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan. F2 · balance_after: Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026. Read SEC document |
| December 31, 2025 Filed Jan 6, 2026 00:05 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 3,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-26-001366 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,460 F1 · price: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan. Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 00:30 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 3,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-25-095744 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,335 F1 · price: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 10:01 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 3,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-25-060671 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,210 F1 · price: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:26 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 16,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015795 · rdgdoc.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,698 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 21:00 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $1.10 | Not disclosed |
DisclosureSEC source: 0001213900-25-027223 · ownership.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2035-03-31 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 21:00 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 625 | $1.10 | $687.50 |
DisclosureSEC source: 0001213900-25-027223 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,085 F1 · security: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:00 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $1.39 | Not disclosed |
DisclosureSEC source: 0001213900-25-000733 · ownership.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-12-31 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:00 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 625 | $1.39 | $868.75 |
DisclosureSEC source: 0001213900-25-000733 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,460 F1 · security: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 10:16 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $2.28 | Not disclosed |
DisclosureSEC source: 0001213900-24-084297 · ownership.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-09-30 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 10:16 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-24-084297 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,835 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 21:54 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $1.56 | Not disclosed |
DisclosureSEC source: 0001213900-24-058703 · ownership.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-06-30 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:54 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-24-058703 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,210 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:20 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 10,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-016019 · rdgdoc.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,620 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| March 31, 2024 Filed Apr 3, 2024 01:34 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $1.95 | Not disclosed |
DisclosureSEC source: 0001213900-24-029545 · ownership.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-03-31 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| March 29, 2024 Filed Apr 3, 2024 01:34 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-24-029545 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,585 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 00:11 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $1.78 | Not disclosed |
DisclosureSEC source: 0001213900-24-000364 · ownership.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2033-12-29 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 00:11 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-24-000364 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,960 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 10:03 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $1.16 | Not disclosed |
DisclosureSEC source: 0001013762-23-000707 · ownership.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2033-09-30 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 10:03 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001013762-23-000707 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,335 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:30 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001213900-23-054869 · ownership.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2033-06-30 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:30 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-23-054869 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,710 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:22 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 7,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-013617 · rdgdoc.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,151 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 19:38 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | $1.44 Strike: $1.44 | $10,800.00 |
DisclosureSEC source: 0001213900-23-026205 · ownership.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2033-03-31 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 19:38 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-23-026205 · ownership.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,085 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:43 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 3,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004566 · rdgdoc.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,414 F1 · shares: Represents restricted stock units that will vest in full on the date of the annual meeting of stockholders in 2023. Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 21:36 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | $2.14 Strike: $2.14 | $16,050.00 |
DisclosureSEC source: 0001019056-23-000011 · volkart.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-12-31 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 21:36 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-23-000011 · volkart.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,460 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 18:53 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | $4.34 Strike: $4.34 | $32,550.00 |
DisclosureSEC source: 0001019056-22-000616 · volkart.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-09-30 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 18:53 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-22-000616 · volkart.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,835 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| July 19, 2022 Filed Aug 8, 2022 20:22 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | $5.16 Strike: $5.16 | $38,700.00 |
DisclosureSEC source: 0001019056-22-000547 · volkart.xml · derivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-07-19 F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 16:12 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 1,211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-22-000495 · volkart.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,210 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| May 24, 2022 Filed May 26, 2022 17:23 UTC | ANTARES PHARMA, INC. ATRS · Entity 126887 | Disposition to issuerStock Option (right to buy) · Derivative | 55,916 | Not disclosed Strike: $3.48 | Not disclosed |
DisclosureSEC source: 0000899243-22-019782 · doc4.xml · derivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,916 shares Expires not disclosed F1 · security: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 12, 2022, by and among the Issuer, Antares Pharma, Inc., a Delaware corporation (the "Company"), Halozyme Therapeutics, Inc., a Delaware corporation ("Parent"), and Atlas Merger Sub, Inc., a Delaware corporation ("Purchaser") and a wholly owned subsidiary of Parent, to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.01 par value per share (each, a "Share") and thereafter merged with and into the Issuer (the "Merger") effective as of May 24, 2022 (the "Effective Time"). F2 · security: (Continued from Footnote 1) At the Effective Time, each Share outstanding immediately prior to the Effective Time (other than Excluded Shares) was converted into the right to receive $5.60 in cash, without interest (the "Merger Consideration") and subject to any withholding of taxes required by applicable legal requirements, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled. F3 · price: Each Company option to purchase Shares ("Company Option") means any option to purchase Shares granted under the Company Equity Plan. At the Effective Time, each Company Option that was then outstanding as of immediately prior to the Effective Time was, to the extent unvested, accelerated and became fully vested and exercisable effective prior to the Effective Time. Each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of Shares subject to such Company Option immediately prior to the Effective Time, multiplied by (ii) the excess of (A) the Merger Consideration over (B) the exercise price payable per Share under such Company Option. F3 · derivative.exercise_date: Each Company option to purchase Shares ("Company Option") means any option to purchase Shares granted under the Company Equity Plan. At the Effective Time, each Company Option that was then outstanding as of immediately prior to the Effective Time was, to the extent unvested, accelerated and became fully vested and exercisable effective prior to the Effective Time. Each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of Shares subject to such Company Option immediately prior to the Effective Time, multiplied by (ii) the excess of (A) the Merger Consideration over (B) the exercise price payable per Share under such Company Option. F3 · derivative.expiration_date: Each Company option to purchase Shares ("Company Option") means any option to purchase Shares granted under the Company Equity Plan. At the Effective Time, each Company Option that was then outstanding as of immediately prior to the Effective Time was, to the extent unvested, accelerated and became fully vested and exercisable effective prior to the Effective Time. Each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of Shares subject to such Company Option immediately prior to the Effective Time, multiplied by (ii) the excess of (A) the Merger Consideration over (B) the exercise price payable per Share under such Company Option. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:02 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 17,943 | $4.18 Strike: $4.18 | $75,001.74 |
DisclosureSEC source: 0001019056-22-000314 · volkart.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,943 Underlying: Common Stock · 17,943 shares Expires 2032-03-31 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grant reported herein, the Reporting Person currently has aggregate options to purchase a total of 90,557 shares of the Issuer. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:02 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 1,737 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-22-000314 · volkart.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,999 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 11:06 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 9,987 | $7.51 Strike: $7.51 | $75,002.37 |
DisclosureSEC source: 0001019056-22-000010 · volkart.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,987 Underlying: Common Stock · 9,987 shares Expires 2031-12-31 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grant reported herein, the Reporting Person currently has aggregate options to purchase a total of 72,614 shares of the Issuer. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 11:06 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 999 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-22-000010 · volkart.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,262 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| October 27, 2021 Filed Oct 29, 2021 18:14 UTC | ANTARES PHARMA, INC. ATRS · Entity 126887 | GrantStock Option (right to buy) · Derivative | 55,916 | $0.00 Strike: $3.48 | $0.00 |
DisclosureSEC source: 0001016169-21-000028 · wf-form4_163554564976041.xml · derivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,916 Underlying: Common Stock · 55,916 shares Expires 2031-10-27 F1 · shares: Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 17:30 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 25,168 | $2.98 Strike: $2.98 | $75,000.64 |
DisclosureSEC source: 0001019056-21-000523 · volkart.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,168 Underlying: Common Stock · 25,168 shares Expires 2031-09-30 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grant reported herein, the Reporting Person currently has aggregate options to purchase a total of 187,880 shares of the Issuer. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 17:30 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 2,517 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-21-000523 · volkart.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,788 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 19:39 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 12,712 | $5.90 Strike: $5.90 | $75,000.80 |
DisclosureSEC source: 0001019056-21-000406 · volkart.xml · derivative · entry 2 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,712 Underlying: Common Stock · 12,712 shares Expires 2031-06-30 F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grant reported herein, the Reporting Person currently has aggregate options to purchase a total of 162,712 shares of the Issuer. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 19:39 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock | 1,271 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-21-000406 · volkart.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,271 F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Read SEC document |
| January 23, 2020 Filed Jan 27, 2020 18:09 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 60,000 | $2.25 Strike: $2.25 | $135,000.00 |
DisclosureSEC source: 0001019056-20-000035 · volkart.xml · derivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 60,000 shares Expires 2030-01-23 F1 · security: This option will vest as to one-third of the shares subject to the option on each annual anniversary of December 31, 2019. Read SEC document |
| December 31, 2019 Filed Jan 27, 2020 18:08 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 90,000 | $2.25 Strike: $2.25 | $202,500.00 |
DisclosureSEC source: 0001019056-20-000033 · volkart.xml · derivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2029-12-31 F1 · security: This option will vest as to one-third of the shares subject to the option on each annual anniversary of December 31, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.